EXPE
Price
$294.74
Change
+$1.81 (+0.62%)
Updated
Jul 31 closing price
Capitalization
35.38B
2 days until earnings call
Intraday BUY SELL Signals
TOUR
Price
$4.96
Change
+$0.01 (+0.20%)
Updated
Jul 31 closing price
Capitalization
53.88M
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EXPE vs TOUR

EXPE vs TOUR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EXPE vs. TOUR commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXPE is a Hold and TOUR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (EXPE: $294.74 vs. TOUR: $4.96)
Brand notoriety: EXPE: Notable vs. TOUR: Not notable
Both companies represent the Consumer Sundries industry
Current volume relative to the 65-day Moving Average: EXPE: 51% vs. TOUR: 19%
Market capitalization -- EXPE: $35.38B vs. TOUR: $53.88M
EXPE [@Consumer Sundries] is valued at $35.38B. TOUR’s [@Consumer Sundries] market capitalization is $53.88M. The market cap for tickers in the [@Consumer Sundries] industry ranges from $149.47B to $0. The average market capitalization across the [@Consumer Sundries] industry is $27.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXPE’s FA Score shows that 3 FA rating(s) are green whileTOUR’s FA Score has 1 green FA rating(s).

  • EXPE’s FA Score: 3 green, 2 red.
  • TOUR’s FA Score: 1 green, 4 red.
According to our system of comparison, EXPE is a better buy in the long-term than TOUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXPE’s TA Score shows that 6 TA indicator(s) are bullish while TOUR’s TA Score has 3 bullish TA indicator(s).

  • EXPE’s TA Score: 6 bullish, 4 bearish.
  • TOUR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EXPE is a better buy in the short-term than TOUR.

Price Growth

EXPE (@Consumer Sundries) experienced а +13.39% price change this week, while TOUR (@Consumer Sundries) price change was -2.75% for the same time period.

The average weekly price growth across all stocks in the @Consumer Sundries industry was +2.52%. For the same industry, the average monthly price growth was -1.88%, and the average quarterly price growth was -0.27%.

Reported Earning Dates

EXPE is expected to report earnings on Aug 05, 2026.

TOUR is expected to report earnings on Aug 14, 2026.

Industries' Descriptions

@Consumer Sundries (+2.52% weekly)

Consumer sundries companies make products that usually do not have another classification, such as lawn and garden products, pest-control products, pet food and pet products like leashes, collars, and harnesses. Central Garden & Pet Company and Dogness (International) Corporation are examples of companies operating in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXPE($35.4B) has a higher market cap than TOUR($53.9M). EXPE has higher P/E ratio than TOUR: EXPE (26.04) vs TOUR (11.19). EXPE YTD gains are higher at: 4.482 vs. TOUR (-3.805). EXPE has higher annual earnings (EBITDA): 3.08B vs. TOUR (36.8M). EXPE has more cash in the bank: 5.79B vs. TOUR (963M). TOUR has less debt than EXPE: TOUR (4.33M) vs EXPE (4.71B). EXPE has higher revenues than TOUR: EXPE (15.2B) vs TOUR (593M).
EXPETOUREXPE / TOUR
Capitalization35.4B53.9M65,677%
EBITDA3.08B36.8M8,372%
Gain YTD4.482-3.805-118%
P/E Ratio26.0411.19233%
Revenue15.2B593M2,563%
Total Cash5.79B963M602%
Total Debt4.71B4.33M108,633%
FUNDAMENTALS RATINGS
EXPE vs TOUR: Fundamental Ratings
EXPE
TOUR
OUTLOOK RATING
1..100
922
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
47100
SMR RATING
1..100
988
PRICE GROWTH RATING
1..100
960
P/E GROWTH RATING
1..100
3055
SEASONALITY SCORE
1..100
n/a38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TOUR's Valuation (1) in the Other Consumer Services industry is significantly better than the same rating for EXPE (90). This means that TOUR’s stock grew significantly faster than EXPE’s over the last 12 months.

EXPE's Profit vs Risk Rating (47) in the Other Consumer Services industry is somewhat better than the same rating for TOUR (100). This means that EXPE’s stock grew somewhat faster than TOUR’s over the last 12 months.

EXPE's SMR Rating (9) in the Other Consumer Services industry is significantly better than the same rating for TOUR (88). This means that EXPE’s stock grew significantly faster than TOUR’s over the last 12 months.

EXPE's Price Growth Rating (9) in the Other Consumer Services industry is somewhat better than the same rating for TOUR (60). This means that EXPE’s stock grew somewhat faster than TOUR’s over the last 12 months.

EXPE's P/E Growth Rating (30) in the Other Consumer Services industry is in the same range as TOUR (55). This means that EXPE’s stock grew similarly to TOUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EXPETOUR
RSI
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
66%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 8 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EXPE
Daily Signal:
Gain/Loss:
TOUR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMMB1.550.02
+1.31%
Chemomab Therapeutics Ltd
OLLI73.470.73
+1.00%
Ollie's Bargain Outlet Holdings
AXON527.762.46
+0.47%
Axon Enterprise
BVFL20.54-0.20
-0.96%
BV Financial
JANX15.17-0.41
-2.63%
Janux Therapeutics

EXPE and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXPE has been closely correlated with BKNG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if EXPE jumps, then BKNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXPE
1D Price
Change %
EXPE100%
+0.62%
BKNG - EXPE
71%
Closely correlated
-0.18%
ABNB - EXPE
53%
Loosely correlated
-0.37%
MMYT - EXPE
48%
Loosely correlated
-0.23%
TRIP - EXPE
46%
Loosely correlated
-0.18%
TNL - EXPE
45%
Loosely correlated
+1.13%
More

TOUR and

Correlation & Price change

A.I.dvisor tells us that TOUR and MED have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TOUR and MED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOUR
1D Price
Change %
TOUR100%
+0.20%
MED - TOUR
22%
Poorly correlated
-0.81%
TNL - TOUR
22%
Poorly correlated
+1.13%
PRSU - TOUR
21%
Poorly correlated
-1.17%
MMYT - TOUR
20%
Poorly correlated
-0.23%
EXPE - TOUR
20%
Poorly correlated
+0.62%
More